Therefore, we speculated that the expressions of CRP and WBCs could help the MDSCs and CD68+CD163+M2-like macrophages to further predict the therapeutic response of NSCLC patients after radiotherapy. This evidence concerns the gene CRP and non-small cell lung carcinoma.